Efficacy of Matrifen in Patients Older Than 18 Years With Severe, Chronic Pain
NCT00556270 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3000
Last updated 2012-05-07
Summary
The aim of the study is to evaluate the efficacy and safety of matrifen in patients with severe and chronic pain who can only be sufficiently treated with opioid analgesics (WHO class 3).
Conditions
- Severe, Chronic Pain
Interventions
- DRUG
-
Matrifen
as defined in the Summary of Product Characteristics (Fachinformation Chapter 4.2)
Sponsors & Collaborators
-
Nycomed
lead INDUSTRY
Principal Investigators
-
Dr. Thomas D. Bethke, PhD, MD · Nycomed Deutschland GmbH, 78467 Konstanz, Germany
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-11-30
- Completion
- 2008-05-31
Countries
- Germany
Study Locations
More Related Trials
-
Switching From Morphine to Methadone. A Clinical, Pharmacological and Pharmacogenetic Study
NCT00184496 ·Status: COMPLETED ·Phase: PHASE3
-
Attenuation of Pain in Men and Women
NCT01220414 ·Status: COMPLETED ·Phase: NA
-
The Effectiveness and Tolerability of Fentanyl Matrix in Chronic Non-cancer Pain; Assessment of Patient's Pain Treatment Goal Achievement
NCT01688583 ·Status: COMPLETED
-
Investigation of Analgesic and Anti-hyperalgesic Effect of Opioids in Experimental Pain
NCT00647127 ·Status: COMPLETED ·Phase: PHASE3
-
Role of Methadone As Co-Opioid Analgesic
NCT00558870 ·Status: TERMINATED ·Phase: PHASE2
-
Long-term Effects of Methadone for Cancer Pain
NCT02856399 ·Status: UNKNOWN
-
Switching From Morphine to Oral Methadone Plus Acetaminophen in the Treatment of Cancer Pain
NCT00525967 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Investigating Composite Biomarkers for Pain Catastrophizing
NCT04787198 ·Status: RECRUITING ·Phase: NA
-
Brain Effects of Opiate Agonist and Antagonist
NCT04342130 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of Peripheral Itch Mechanisms Following Injection of Morphine (Second Sub-Project)
NCT04700007 ·Status: COMPLETED ·Phase: NA
-
pRedicting the Long-term rEsponse of High Frequency sPinal cOrd sTimulation in Patients With Failed Back Surgery Syndrome.
NCT04500691 ·Status: COMPLETED
-
Methadone Versus Morphine for Cancer-Related Pain
NCT00573937 ·Status: TERMINATED ·Phase: PHASE2
-
Open Label, Safety Study of EN3270 in Patients With Moderate to Severe Non-malignant, Chronic Pain
NCT00485225 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Guanfacine on Opioid-induced Hyperalgesia (OIH) and Tolerance
NCT01681264 ·Status: TERMINATED ·Phase: PHASE4
-
Opioid Rotation Versus Combination for Chronic Uncontrolled Cancer Pain
NCT00478101 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Hydromorphone Hydrochloride Extended-Release Compared to Placebo in Subjects With Persistent Pain
NCT00365898 ·Status: TERMINATED ·Phase: PHASE3
-
Comparison of VER-01 to Opioids in Patients With Chronic Non-specific Low Back Pain
NCT05610813 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Oxmorphone Extended Release in Chronic Non-malignant Pain
NCT00225797 ·Status: COMPLETED ·Phase: PHASE3
-
Phase III Clinical Trial of Fentanyl Transdermal Matrix Patch, in the Management of Chronic Intractable Pain- Assessment of Effectiveness, Safety and Pharmacokinetics
NCT00216684 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of A Single Dose Combination of Methadone and Morphine With Morphine Alone for Treating Post-operative Pain
NCT00142519 ·Status: COMPLETED ·Phase: PHASE2
-
Prospective Study About Clinical and Pharmacogenetic Safety of Opioid Use for Chronic Pain
NCT00916890 ·Status: SUSPENDED ·Phase: PHASE4
-
Pain: Screen and Treat
NCT01716780 ·Status: UNKNOWN ·Phase: PHASE3
-
Morphine After Radiofrequency Ablation of Painful Bone Metastases in Patients With Cancer
NCT00712712 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety Study of NKTR-181 in Opioid-Naive Subjects With Low Back Pain
NCT02362672 ·Status: COMPLETED ·Phase: PHASE3
-
QSPainRelief-STRAT
NCT06244706 ·Status: NOT_YET_RECRUITING ·Phase: NA